시장보고서
상품코드
1271224

세계의 항체 시장 : 약제 유형별(모노클로날 항체, 폴리클로날 항체, 항체 약물 복합체), 질환 적응증별, 최종 사용자별, 지역별 - 규모, 점유율, 전망, 기회 분석(2023-2030년)

Antibodies Market, By Drug Type (Monoclonal antibodies, Polyclonal antibodies, Antibody-drug complexes, by Disease Indication By End User, And by Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

발행일: | 리서치사: Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

항체는 암, 자가면역 질환, 혈액 질환, 감염증 등 질환 치료 용도로 사용됩니다. 암 유병률 증가는 시장 제조업체 성장에 유리한 기회를 창출할 것으로 기대됩니다. 항체 제품은 생물학적 치료 제품에 속합니다. 생물학적 제형 제조업체는 제품을 시장에 내놓기 전에 미국 식품약국 승인(의약품과 유사한 승인)을 받아야 합니다. 그러나 의약품과는 달리, 생물학적 제제는 생물학적 제제 평가 연구 센터(CBER)에 생물학적 제제 승인 신청(BLA)을 제출해야 합니다. 또한 다양한 정부 당국이 개혁을 더함으로써 약가의 억제, 인하에 힘을 쏟고 있습니다. 예를 들어 미국 정부는 2019년 2월에 의약품 제조사가 약국 복리 후생 매니저와 같은 유통 채널 파트너와 거래를 억제함으로써 메디케어 환자 자기 부담액을 줄이는 것을 목표로 하고 있습니다.

시장 역학

제품 포트폴리오를 확대하기 위해 시장 주요 플레이어가 협업 및 파트너십과 같은 무기 성장 전략을 채택하는 것이 증가하고 있으며 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어 2020년 1월, 바이오 의약품인 MorphoSys AG는 다국적 제약 회사인 Incyte Corporation과 MorphoSys CD19 인간화 Fc-변형 모노클로날 항체인 타파시타맙 개발 및 상업화에 대해 협력하고 있습니다.

조사 주요 특징

  • 세계의 항체(Antibodies) 시장을 상세히 분석하여 2022년을 기준으로 예측 기간(2023-2030년) 동안의 시장 규모 및 연간 평균 성장률(CAGR%)을 게재하고 있습니다.
  • 다양한 부문 잠재 수익 기회를 밝히고, 시장 매력적인 투자 제안 매트릭스를 설명합니다.
  • 또한 시장 촉진 요인, 억제 요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역 전망, 주요 기업이 채택하는 경쟁 전략 중요 고려 사항을 제공합니다.
  • 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등 다음 매개변수를 기반으로 세계의 항체 시장 주요 플레이어를 프로파일링합니다.
  • 본 연구 일부로 다루는 주요 기업은 Novartis AG, F. Hoffmann-La Roche Ltd., Johnson& Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Amgen Inc ., Biogen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Sanofi, Eli Lilly and Co., Iovance Biotherapeutics, Inc., Ultragenyx Pharmaceutical Inc., and Kyowa Kirin Co., Ltd.입니다.
  • 보고서에서 얻은 지식을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 타이핑, 시장 확대, 마케팅 전술 정보를 바탕으로 결정을 내릴 수 있습니다.
  • 세계의 항체 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 업계의 다양한 이해관계자를 지원합니다.
  • 이해관계자는 세계의 항체 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 전제 조건

  • 조사 목적
  • 전제 조건
  • 약어

제2장 시장 전망

  • 리포트 주요 요약
    • 시장 정의와 범위
  • 주요 요약
    • 시장 스냅샷 : 약물 유형별
    • 시장 스냅샷:질환 적응증별
    • 시장 스냅샷 : 최종 사용자별
    • 시장 스냅샷 : 지역별
  • 기회 분석 지도(COM)

제3장 시장 역학, 법규제, 동향 분석

  • 시장 역학
    • 촉진 요인
    • 억제 요인
    • 시장 기회
    • 영향도 분석
    • 주요 하이라이트
    • 제품 발매
    • 기술적 진보
    • PEST 분석
    • 법규제 시나리오
    • M&A(합병, 인수)

제4장 항체 시장-코로나바이러스(COVID-19) 판데믹별 영향

  • 경제적 영향
  • COVID-19 역학에 대해
  • 수급에 미치는 영향

제5장 항체 시장, 약제 유형별(2017-2030년)

  • 모노클로날 항체
  • 폴리클로날 항체
  • 항체-약물 복합체(ADC)

제6장 항체 시장, 질환 적응증별(2017-2030년)

  • 중추 신경계 질환
  • 심혈관 질환
  • 자가면역질환
  • COVID-19
  • 기타

제7장 항체 시장, 최종 사용자별(2017-2030년)

  • 병원
  • 장기 요양 시설
  • 연구기관

제8장 항체 시장, 지역별(2017-2030년)

  • 북미
  • 미국
  • 캐나다
  • 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 그 외 라틴아메리카
  • 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양 지역
  • 중국
  • 인도
  • 일본
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양 지역
  • 중동지역
  • GCC
  • 이스라엘
  • 기타 중동 지역
  • 아프리카
  • 북아프리카
  • 중앙 아프리카
  • 남아프리카

제9장 경쟁 상황

  • Novartis International AG
  • Hoffmann-La Roche Ltd.
  • Johnson& Johnson Services, Inc.
  • Takeda Pharmaceutical Company Limited
  • Amgen Inc.
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • AbbVie Inc.
  • Sanofi SA
  • Eli Lilly and Co.
  • Iovance Biotherapeutics, Inc.
  • Ultragenyx Pharmaceutical Inc.
  • Kyowa Kirin Co., Ltd.

제10장 섹션

  • 조사 방법에 대해
  • 출판사에 대해
NJH 23.05.26

Antibodies are used in therapeutic applications for the treatment of diseases such as cancer, autoimmune diseases, hematological diseases, infectious diseases, and others. The increasing prevalence of cancer is expected to create lucrative opportunities for the growth of manufacturers in the market. Antibodies products come under biological therapeutic products. Biologic manufacturers require approval (similar to pharma drug approval) from the U.S. Food & Drug Administration prior to bringing the product to the market. However, unlike drugs, biologics require Biologics License Applications (BLA) to be filed with the Center for Biologics Evaluation and Research (CBER). Moreover, various government authorities are focused on controlling/lowering drug prices by adding reforms. For instance, the U.S. government is seeking to lower patients' out-of-pocket spending in Medicare by curbing deals that drug manufacturers make with its distribution channel partners such as pharmacy benefit managers, in February 2019 (these deals are responsible for increasing list price of drugs).

Market Dynamics

Increasing adoption of inorganic growth strategies, such as collaboration and partnership by key players in the market to expand their product portfolio, is expected to drive market growth over the forecast period. For instance, in January 2020, MorphoSys AG, biopharmaceutical company collaborated with Incyte Corporation a multinational pharmaceutical company for the development and commercialization of MorphoSys' tafasitamab, a humanized Fc-engineered monoclonal antibody against CD19.

Key features of the study:

  • This report provides in-depth analysis of the global antibodies market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global antibodies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study are Key companies covered as a part of this study include Novartis AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Sanofi, Eli Lilly and Co., Iovance Biotherapeutics, Inc., Ultragenyx Pharmaceutical Inc., and Kyowa Kirin Co., Ltd.
  • Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global antibodies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibodies market

Detailed Segmentation:

  • Global Antibodies Market, By Drug Type:
    • Monoclonal antibodies
    • Polyclonal antibodies
    • Antibody-drug complexes (ADCs)
  • Global Antibodies Market, By Disease Indication:
    • CNS Disorders
    • Cardiovascular Diseases
    • Cancer
    • Autoimmune Disorders
    • COVID-19
    • Others
  • Global Antibodies Market, By End User:
    • Hospitals
    • Long-term Care Facilities
    • Research institutes
  • Global Antibodies Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Novartis International AG*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • F. Hoffmann-La Roche Ltd.
    • Johnson & Johnson Services, Inc.
    • Takeda Pharmaceutical Company Limited
    • Amgen Inc.
    • Biogen Inc.
    • Bristol-Myers Squibb Company
    • AbbVie Inc.
    • Sanofi S.A.
    • Eli Lilly and Co.
    • Iovance Biotherapeutics, Inc.
    • Ultragenyx Pharmaceutical Inc.
    • Kyowa Kirin Co., Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Type
    • Market Snapshot, By Disease Indication
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product Launch
    • Technological Advancements
    • PEST Analysis
    • Regulatory Scenario
    • Mergers and Acquisitions

4. Global Antibodies Market- Impact of Coronavirus (Covid-19) Pandemic

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Antibodies Market, By Drug Type, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Monoclonal Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Polyclonal Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Antibody-drug complexes (ADCs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Antibodies Market, By Disease Indication, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • CNS Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Cardiovascular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Autoimmune Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • COVID-19
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$

7. Global Antibodies Market, By End User, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segments Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Long-term Care Facilities
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Research institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Antibodies Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Novartis International AG*
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson Services, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Takeda Pharmaceutical Company Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Biogen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bristol-Myers Squibb Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AbbVie Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi S.A.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eli Lilly and Co.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Iovance Biotherapeutics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ultragenyx Pharmaceutical Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Kyowa Kirin Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Section

  • Research Methodology
  • About Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제